CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 130 enrolled
Drug / intervention
senofilcon Adevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03742271
NCT03742271N/ACompleted
CompareCT.gov

Evaluation of Senofilcon A With New UV-blocker on a Neophyte Population

Johnson & Johnson Vision Care, Inc.·interventional·Posted Nov 15, 2018·Updated Mar 13, 2020

In Brief

A clinical study evaluating senofilcon A for Visual Acuity. Completed, enrolled 130 participants across 11 sites.

Detailed Summary

This is a 5-visit, single-arm, open-label, dispensing study. Each subject will be bilaterally fit with the test article for approximately 4 weeks of reusable daily wear with lens replacement occurring 2-weeks after initial dispensing. After 4 weeks of study lens wear, subjects will return to their habitual spectacles for one week.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVisual Acuity
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedNov 15, 2018
Enrollment StartOct 30, 2018
Primary CompletionMar 31, 2019
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 7.6 years ago

Interventions

senofilcon Adevice

TEST Lens